Tianjin Nucleic Acid Drug Industry Intellectual Property Operation Center Officially Launches in TEDA
Recently, the Tianjin Nucleic Acid Drug Industry Intellectual Property Seminar and the opening ceremony of the Nucleic Acid Drug Industry Intellectual Property Operation Center (hereinafter referred to as the Center) were held in TEDA. The Center is led by TEDA-based Cosychem Technology (Tianjin) Co., Ltd. Cosychem will establish multiple production pipelines and provide a full-cycle service chain for intellectual property, covering creation, utilization, protection, and management.
During the event, Tianjin Intellectual Property Protection Center and Binhai Intellectual Property Protection Center signed agreements with the Tianjin Nucleic Acid Industry Alliance. The three parties will collaborate vigorously to advance the establishment of the Center. They will comprehensively enhance the patent information service capabilities within the nucleic acid industry, leveraging regional and industry-specific advantages to further elevate the quality of intellectual property creation. A key initiative involves the establishment of an expert consultation mechanism to offer intellectual property creation, utilization, and protection guidance to enterprises. Moreover, they will utilize various online and offline channels to consistently bolster the promotion of intellectual property operation policies and service advantages. This will facilitate the seamless connection of supply and demand information related to intellectual property operation and protection, ultimately accelerating the realization of intellectual property value.
In addition, the Center will also engage in enterprise intellectual property value assessment and intellectual property mortgage financing. It will create a finance innovation platform for intellectual property securitization, promoting the deep integration of technology, capital, and industry, and accelerating the development of the nucleic acid drug industry cluster. This effort aims to enhance the core competitiveness and influence of Tianjin's nucleic acid drug industry both domestically and internationally.
First, please LoginComment After ~